Grainne Quinn - 06 Mar 2023 Form 4 Insider Report for PERRIGO Co plc (PRGO)

Role
EVP, Chief Medical Officer
Signature
/s/ Victor Torres, attorney-in-fact for Ms. Grainne Quinn
Issuer symbol
PRGO
Transactions as of
06 Mar 2023
Transactions value $
$40,727
Form type
4
Filing time
08 Mar 2023, 15:55:25 UTC
Previous filing
07 Mar 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRGO Ordinary Shares Options Exercise $84.8K +2.25K +17.33% $37.71 15.2K 07 Mar 2023 Direct F1
transaction PRGO Ordinary Shares Tax liability -$44.1K -1.17K -7.68% $37.71 14.1K 07 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRGO Restricted Stock Units Options Exercise -2.25K -33.34% 4.5K 07 Mar 2023 Ordinary Shares 2.25K Direct F1, F2, F3
transaction PRGO Restricted Stock Units Award +5.28K 5.28K 06 Mar 2023 Ordinary Shares 5.28K Direct F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of service-based restricted stock units granted on 7 March 2022.
F2 Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
F3 Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 7 March 2023.
F4 Grant of service-based restricted stock units granted on 6 March 2023.
F5 Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 March 2024.